Watchlist
Loading...
US Stock MarketDetailed Quotes

GMAB Genmab

Watchlist
31.915 -0.355-1.10% Trading 12/05 11:00 ET
32.130High31.840Low134.28KVolume
Intraday
  • 5D
  • 1D
  • 1W
  • 1M
  • 1Q
  • 1Y

About Genmab Company

Genmab A/S is an international biotechnology company, which engages in the development of human antibody therapeutics for the treatment of cancer and other diseases. Its product pipeline include daratumumab, marketed as DARZALEX for the treatment of certain indications of multiple myeloma; teprotumumab-trbw marketed as TEPEZZA for the treatment of thyroid eye disease; and ofatumumab, marketed as Arzerra for the treatment of certain indications of chronic lymphocytic leukemia. The company was founded by Donald Lee Drakeman, Florian Schonharting, and Jan G. J. van de Winkel on June 11, 1998 and is headquartered in Copenhagen, Denmark.

Revenue Breakdown

Business Currency:DKK
2022/12/31
Stock NameRevenueRatio
Single segment14.6B100.00%

Comments

Read more
Paper Trade Start
Symbol
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Claim up to $1 million virtual fund, join moomoo paper trading today! Claim Now >